Objective. To investigate the association of β2- glycoprotein I (β2GPI) with lipid rafts in monocytic cells and to evaluate the proinflammatory and procoagulant effects of anti- β2GPI binding to its target antigen on the monocyte plasma membrane. Methods. Human monocytes were fractionated by sucrose density-gradient centrifugation and analyzed by Western blotting. Immunoprecipitation experiments were performed to analyze the association of β2GPI with lipid rafts and the possible interaction of β2GPI with annexin A2 and Toll-like receptor 4 (TLR-4). Monocytes were then stimulated with affinity-purified anti-β2GPI antibodies from patients with the antiphospholipid syndrome (APS). Interleukin-1 receptor-associated kinase (IRAK) phosphorylation...
Stimulated human monocytes undergo an intense trafficking of arachidonic acid (AA) among glycerophos...
In this study we analyzed whether anti-β2-GPI antibodies from patients with APS induce the endotheli...
Anti-β2-glycoprotein I antibodies (aβ2GPI) represent a potential pathogenic candidate for coronary a...
Antiphospholipid syndrome (APS) is characterized by recurrent arterial/venous thrombosis and miscarr...
A major mechanism of hypercoagulability in the antiphospholipid syndrome (APS) is antiphospholipid A...
It is well known that monocytes may play an active role in thrombogenesis, since they may express on...
The antiphospholipid syndrome (APS) is an autoimmune disease associated with arterial or venous thro...
The antiphospholipid syndrome (APS) is an autoimmune disease associated with arterial or venous thro...
Antiphospholipid syndrome (APS) is characterized by recurrent thrombosis or pregnancy morbidity asso...
beta(2)-glycoprotein I (beta(2)GPI) is the major antigenic target for antiphospholipid Abs. Anti-bet...
The thrombogenic effect of \u3b22-glycoprotein I (\u3b22GPI)-dependent anti-phospholipid antibodies ...
Background: Antiphospholipid Syndrome (APS) is characterized by recurrent fetal losses and arterial/...
Upregulation of the procoagulant activity of monocytes by antibodies to beta2-glycoprotein I (β2GPI)...
The effects of IgG from patients with the antiphospholipid syndrome (APS) upon monocyte activation h...
The effects of IgG from patients with the antiphospholipid syndrome (APS) upon monocyte activation h...
Stimulated human monocytes undergo an intense trafficking of arachidonic acid (AA) among glycerophos...
In this study we analyzed whether anti-β2-GPI antibodies from patients with APS induce the endotheli...
Anti-β2-glycoprotein I antibodies (aβ2GPI) represent a potential pathogenic candidate for coronary a...
Antiphospholipid syndrome (APS) is characterized by recurrent arterial/venous thrombosis and miscarr...
A major mechanism of hypercoagulability in the antiphospholipid syndrome (APS) is antiphospholipid A...
It is well known that monocytes may play an active role in thrombogenesis, since they may express on...
The antiphospholipid syndrome (APS) is an autoimmune disease associated with arterial or venous thro...
The antiphospholipid syndrome (APS) is an autoimmune disease associated with arterial or venous thro...
Antiphospholipid syndrome (APS) is characterized by recurrent thrombosis or pregnancy morbidity asso...
beta(2)-glycoprotein I (beta(2)GPI) is the major antigenic target for antiphospholipid Abs. Anti-bet...
The thrombogenic effect of \u3b22-glycoprotein I (\u3b22GPI)-dependent anti-phospholipid antibodies ...
Background: Antiphospholipid Syndrome (APS) is characterized by recurrent fetal losses and arterial/...
Upregulation of the procoagulant activity of monocytes by antibodies to beta2-glycoprotein I (β2GPI)...
The effects of IgG from patients with the antiphospholipid syndrome (APS) upon monocyte activation h...
The effects of IgG from patients with the antiphospholipid syndrome (APS) upon monocyte activation h...
Stimulated human monocytes undergo an intense trafficking of arachidonic acid (AA) among glycerophos...
In this study we analyzed whether anti-β2-GPI antibodies from patients with APS induce the endotheli...
Anti-β2-glycoprotein I antibodies (aβ2GPI) represent a potential pathogenic candidate for coronary a...